Differentiation and characterization of conformational alpha-synuclein strains associated with Parkinson's disease and related synucleinopathies

University Of Texas Hlth Sci Ctr Houston, Houston TX

Investigators

Linked publications & trials

Abstract

Synucleinopathies are a diverse group of neurodegenerative diseases characterized by misfolding, aggregation and accumulation of misfolded alpha-synuclein (?Syn) which include Parkinson?s disease (PD), multiple system atrophy (MSA) and dementia with Lewy bodies (DLB). Despite sharing the same pathological protein, different clinical and pathological phenotypes are typically observed in different synucleinopathies. One of the main obstacles to develop effective treatments for synucleinopathies is the lack of an early diagnosis before the onset of brain damage and clinical symptoms of the disease. Clinically, it is very challenging to discriminate between some of the synucleinopathies (e.g. PD and MSA), especially at early stages of the disease. This is an important problem because these diseases have different prognosis and modes of treatment. Recently, we developed the protein misfolding cyclic amplification (PMCA, also known as RT- QuIC) technology for highly sensitive and specific detection of ?Syn oligomers in biological fluids of patients affected by synucleinopathies. ?Syn-PMCA utilizes the prion-like seeding mechanism to cyclically amplify the process of protein misfolding, enabling the efficient amplification of small quantities of ?Syn oligomers, facilitating their detection. We have evidence that the product of ?Syn-PMCA coming from CSF samples of patients affected by PD and MSA can be experimentally distinguished. Thus, we hypothesize that ?Syn aggregates associated with different synucleinopathies correspond to different conformational strains/ sub-strains of ?Syn that can be faithfully amplified by ?Syn-PMCA and the product can be differentiated by their biochemical, structural and biological properties. In this study, our main goal is to detect, differentiate and amplify minute amounts of ?Syn strains/ sub-strains from biological fluids and brain tissue of patients with synucleinopathies by an in-vitro seeding/ amplification assay, and characterize these ?Syn conformational aggregates using various biochemical, structural, and biological techniques. The findings obtained here will lay the foundation towards the development of a biochemical test for differential diagnosis of synucleinopathies by sensitive and specific detection of different ?Syn strains/sub-strains, which will help in patients? stratification, target enrollment for clinical trial and personalized treatment.